Related Experiment Video
Updated: Aug 14, 2026

Modeling and Evaluation of Murine Diabetic Cardiomyopathy Model
Published on: November 29, 2024
Effect of glycemic control on left ventricular diastolic function in type 1 diabetes mellitus
Anna M Grandi1, Eliana Piantanida, Ivano Franzetti
1Department of Clinical Medicine, University of Insubria, Insubria, Italy. amgrandi@libero.it
Insights
Improving glycemic control in type 1 diabetes can significantly enhance left ventricular (LV) diastolic function. Tight blood sugar management may prevent or reverse diastolic dysfunction in diabetic heart disease.
Area of Science:
- Cardiology
- Endocrinology
- Diabetology
Background:
- Diabetic heart disease is often characterized by left ventricular (LV) diastolic dysfunction.
- Type 1 diabetes mellitus (T1DM) poses a significant risk for cardiovascular complications.
- Effective management of hyperglycemia is crucial for mitigating diabetic complications.
Purpose of the Study:
- To investigate the impact of improved glycemic control on LV diastolic function in individuals with T1DM.
- To assess the relationship between glycated hemoglobin levels and diastolic parameters over time.
- To determine if enhanced glycemic control can ameliorate or prevent diastolic dysfunction in T1DM.
Main Methods:
- Prospective study involving 36 normotensive T1DM patients with inadequately controlled glycemia (HbA1c >7%).
- Insulin therapy was adjusted to improve glycemic control over 6 and 12 months.
- Evaluations included glycated hemoglobin, LV echocardiography, 24-hour blood pressure monitoring, and laboratory tests.
Main Results:
- After 6 months, mean glycated hemoglobin significantly decreased, and LV diastolic parameters showed significant improvement.
- LV anatomy and systolic function remained unchanged, indicating isolated diastolic dysfunction improvement.
- Changes in diastolic parameters were inversely correlated with changes in glycated hemoglobin.
Conclusions:
- A strong association exists between glycemic control and LV diastolic function in normotensive T1DM patients.
- Improved glycemic control leads to significant improvements in diastolic function.
- Tight glycemic control offers a potential strategy for preventing or reversing diastolic dysfunction in T1DM.
Abstract:
Left ventricular (LV) diastolic dysfunction is a main feature of diabetic heart disease. The aim of this prospective study was to evaluate the influence of glycemic control on diastolic function in type 1 diabetes mellitus. Thirty-six normotensive (24-hour blood pressure <130/80 mm Hg) subjects with inadequately controlled (glycated hemoglobin >7%) type 1 diabetes, without clinically detectable heart disease, were enrolled. After the basal evaluation, insulin therapy was modified to improve glycemic control. Glycated hemoglobin, LV echocardiography, 24-hour blood pressure monitoring, and laboratory tests were repeated after 6 months in all patients and after 12 months in 27 patients. At the basal evaluation, LV anatomy and systolic function were normal in all, and diastolic function was impaired in 14 patients. After 6 months, the mean values of body mass index, 24-hour blood pressure, and LV anatomy and systolic function were unchanged; mean glycated hemoglobin was decreased (p < 0.001), and mean values of diastolic parameters were significantly improved. After 12 months, the mean values of all blood pressure, metabolic, and LV parameters were unchanged. Percent changes of diastolic parameters were inversely correlated with percent changes of glycated hemoglobin, considering changes from the basal to the 6-month evaluation, as well as changes from the 6- to the 12-month evaluation. In conclusion, in normotensive patients with type 1 diabetes, a close relation was found between glycemic control and LV diastolic function, which improves when glycemic control improves. Therefore, diastolic dysfunction can be prevented or reversed, at least partly, by tight glycemic control.
Related Concept Videos
Type I Diabetes II: Pathophysiology
Type II Diabetes II: Pathophysiology
Type I Diabetes III: Clinical Manifestations
Diabetes Mellitus: Type 2 and Gestational
Type I Diabetes I: Introduction
Diabetes Mellitus: Overview and Type I Subtype
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
